CIC
RMD icon

Crawford Investment Counsel’s ResMed RMD Stock Holding History

Crawford Investment Counsel’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$281K Sell
1,251
-857
-41% -$214K ﹤0.01% 276
2025
Q4 		$508K Sell
2,108
-202
-9% -$51.7K 0.01% 253
2025
Q3 		$632K Sell
2,310
-940
-29% -$257K 0.01% 236
2025
Q2 		$839K Sell
3,250
-4,384
-57% -$1.05M 0.01% 216
2025
Q1 		$1.71M Buy
7,634
+461
+6% +$108K 0.03% 189
2024
Q4 		$1.64M Buy
7,173
+1,051
+17% +$253K 0.03% 191
2024
Q3 		$1.49M Buy
6,122
+80
+1% +$17.9K 0.03% 192
2024
Q2 		$1.16M Buy
6,042
+2
+0% +$406 0.02% 189
2024
Q1 		$1.2M Buy
6,040
+524
+9% +$96K 0.02% 183
2023
Q4 		$949K Buy
+5,516
New +$847K 0.02% 191
2023
Q3 		– Sell
-1,001
Closed -$219K – 275
2023
Q2 		$219K Hold
1,001
– – ﹤0.01% 269
2023
Q1 		$219K Sell
1,001
-11
-1% -$2.39K ﹤0.01% 266
2022
Q4 		$211K Hold
1,012
– – ﹤0.01% 269
2022
Q3 		$221K Sell
1,012
-45
-4% -$10.2K 0.01% 263
2022
Q2 		$222K Sell
1,057
-121
-10% -$25.8K ﹤0.01% 268
2022
Q1 		$286K Hold
1,178
– – 0.01% 262
2021
Q4 		$307K Sell
1,178
-19
-2% -$4.93K 0.01% 256
2021
Q3 		$315K Buy
1,197
+6
+0.5% +$1.64K 0.01% 260
2021
Q2 		$294K Buy
1,191
+19
+2% +$3.99K 0.01% 260
2021
Q1 		$227K Buy
1,172
+11
+0.9% +$2.21K 0.01% 271
2020
Q4 		$247K Buy
+1,161
New +$231K 0.01% 256
2020
Q3 		– Sell
-1,161
Closed -$223K – 272
2020
Q2 		$223K Buy
+1,161
New +$190K 0.01% 252

Other funds holding RMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Crawford Investment Counsel's RMD Position: Q1 2026 in Review

Crawford Investment Counsel reduced its ResMed (RMD) stake by 41% in Q1 2026, selling an estimated $214K and leaving 1,251 shares worth $281K. The position accounts for ﹤0.01% of the portfolio, ranked #276.

Crawford Investment Counsel first reported a position in RMD in Q2 2020 and has held it in 22 quarters since. The position peaked at $1.71M in Q1 2025. 938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

  • Crawford Investment Counsel held 1,251 shares of ResMed worth $281K as of Q1 2026.
  • Crawford Investment Counsel sold 857 ResMed shares in Q1 2026, an estimated $214K.
  • ResMed made up ﹤0.01% of Crawford Investment Counsel's portfolio in Q1 2026, its #276 holding.
  • Crawford Investment Counsel first reported a position in ResMed in Q2 2020 and has held it in 22 quarters since.
  • Crawford Investment Counsel's ResMed position peaked at $1.71M in Q1 2025.
  • 938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on Crawford Investment Counsel's 13F filing for Q1 2026, filed 15 May 2026.